Medical device company CVRx extends series F financing to $42m, with extra $12m from investors including DaVita HealthCare Partners, in order to advance clinical trials for its system to treat hypertension and heart failure.

Immune Design raises up to $49m series C financing from a syndicate including new investor Sanofi-Genzyme BioVentures, to advance its cancer immunotherapy product pipeline.

The University of North Carolina Chapel Hill receives $54.6m to boost its life sciences tech transfer.

And when corporations perceive public market mis-valuation they can step in.

And when corporations perceive public market mis-valuation they can step in while most universities remain bystanders.